RESUMO
Although many genes that regulate floral development have been identified in Arabidopsis thaliana, relatively few are known in the grasses. In normal maize (Zea mays), each spikelet produces an upper and lower floral meristem, which initiate floral organs in a defined phyllotaxy before being consumed in the production of an ovule. The bearded-ear (bde) mutation affects floral development differently in the upper and lower meristem. The upper floral meristem initiates extra floral organs that are often mosaic or fused, while the lower floral meristem initiates additional floral meristems. We cloned bde by positional cloning and found that it encodes zea agamous3 (zag3), a MADS box transcription factor in the conserved AGAMOUS-LIKE6 clade. Mutants in the maize homolog of AGAMOUS, zag1, have a subset of bde floral defects. bde zag1 double mutants have a severe ear phenotype, not observed in either single mutant, in which floral meristems are converted to branch-like meristems, indicating that bde and zag1 redundantly promote floral meristem identity. In addition, BDE and ZAG1 physically interact. We propose a model in which BDE functions in at least three distinct complexes to regulate floral development in the maize ear.
Assuntos
Flores/crescimento & desenvolvimento , Proteínas de Domínio MADS/metabolismo , Proteínas de Plantas/metabolismo , Zea mays/genética , Clonagem Molecular , Flores/genética , Regulação da Expressão Gênica de Plantas , Proteínas de Domínio MADS/genética , Meristema/genética , Meristema/crescimento & desenvolvimento , Mutação , Proteínas de Plantas/genética , Mapeamento de Interação de Proteínas , RNA de Plantas/genética , Zea mays/crescimento & desenvolvimento , Zea mays/metabolismoRESUMO
BACKGROUND: Invitrogen Gateway technology exploits the integrase/att site-specific recombination system for directional cloning of PCR products and the subsequent subcloning into destination vectors. One or three DNA segments can be cloned using Gateway or MultiSite Gateway respectively. A vast number of single-site Gateway destination vectors have been created while MultiSite Gateway is limited to few destination vectors and therefore to few applications. The aim of this work was to make the MultiSite Gateway technology available for multiple biological purposes. RESULTS: We created a construct, pDONR-R4-R3, to easily convert any available Gateway destination vector to a MultiSite Gateway vector in a single recombination reaction. In addition, we designed pDONR-R4-R3 so that DNA fragments already cloned upstream or downstream of the Gateway cassette in the original destination vectors can still be utilized for promoter-gene or translational fusions after the conversion. CONCLUSION: Our tool makes MultiSite Gateway a more widely accessible technology and expands its applications by exploiting all the features of the Gateway vectors already available.
